Stem Cell Therapy for COVID-19-related Acute Respiratory Distress Syndrome (ARDS)
Talk recorded by CureTalks on July 21, 2020
Acute respiratory distress syndrome (ARDS) is a very serious complication for many patients suffering from COVID-19, and is believed to account for about 80 percent of the deaths in ventilated patients. There is no proven or FDA-approved treatment for it, other than oxygen therapy and fluid management.
In this CureTalk interview, Nimesh Desai, MD, PhD, Director of the Thoracic Aortic Surgery Research Program, explains the study he is leading to investigate the effectiveness of stem cell therapy in treating COVID-19-related ARDS.